Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Debt / NOTE 2.250% 4/0
-
Number of holders
-
42
-
Total principal
-
566M
-
Principal change
-
-4.46M
-
Total reported value, excl. options
-
$657M
-
Value change
-
-$1.52M
-
Number of buys
-
25
-
Number of sells
-
-15
-
Price
-
$1.17
Significant Holders of ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 as of Q3 2024
filings reported holding 04351PAD3 - ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 as of Q3 2024.
ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 has 42 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $566M of principal
.
Largest 10 bondholders include Linden Advisors LP ($175M of principal), WOLVERINE ASSET MANAGEMENT LLC ($85.3M of principal), FRANKLIN RESOURCES INC ($47.7M of principal), READYSTATE ASSET MANAGEMENT LP ($31M of principal), Davidson Kempner Capital Management LP ($27.5M of principal), PFM Health Sciences, LP ($23M of principal), Point72 Asset Management, L.P. ($17M of principal), LAZARD ASSET MANAGEMENT LLC ($14.5M of principal), ZAZOVE ASSOCIATES LLC ($13.1M of principal), and Polar Capital Holdings Plc ($12.8M of principal).
This table shows the top 42 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.